Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG: Placebo to Ertugliflozin
- DRUG: Ertugliflozin 1 mg
- DRUG: Ertugliflozin 5 mg
- DRUG: Ertugliflozin 25 mg
- DRUG: Sitagliptin 100 mg
- DRUG: Placebo to Sitagliptin
- DRUG: Metformin
Sponsor
Merck Sharp & Dohme LLC
Collaborators